DXSP DXS International PLC

Director/PDMR Shareholding

Director/PDMR Shareholding
EN
01/10/2020

Underlying

DXSPDXS International PLC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DXS International PLC

 PRESS RELEASE
Free
DXSP DXS Internation...

DXS INTERNATIONAL PLC (AQSE: DXSP) Notification of Director / PDMR Dea...

DXS INTERNATIONAL PLC (AQSE: DXSP) Notification of Director / PDMR Dealing DXS INTERNATIONAL PLC (AQSE: DXSP) Notification of Director / PDMR Dealing DXS INTERNATIONAL PLC The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems, has received notification that on 11 November, Mr Bob Sutcliffe, the Chairman, purchased 50,000 Ordinary Shares in the Company at a price of 1.30p per share. Following this transaction Mr Sutcliffe and his wife’s interest in DXS Ordinary Shares...

November 11, 2025 1 EN
Hybridan Team ... (+2)
  • Hybridan Team
  • Jon Levinson
DXSP DXS Internation...

Hybridan Research: DXS International plc: NHS Opportunity Remains

Despite bureaucratic headaches, the final results to 30 April report a 5% increase in revenue to £3.5m and a reduced loss to £94.8k. The P&L comparison with 2024 is awkward due to changes in accounting practises and the £4.7m impairment charge. The FY 2025 loss was affected by a sharp decline in allowable R&D which was down to £80k from £212k due to HMRC’s new restrictions on overseas development. DXS continues to significantly invest in innovation and developing solutions. These costs are now ...

DXSP DXS INTERNATIONAL PLC
10/31/25 October 31, 2025 1 EN
 PRESS RELEASE
Free
DXSP DXS Internation...

DXS International plc ((AQSE: DXSP) - Final Results

DXS International plc ((AQSE: DXSP) - Final Results DXS INTERNATIONAL PLC (AQSE: DXSP) ANNUAL RESULTS for the year ended 30 April 2025 The Board of DXS International plc (“the Company”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, is pleased to announce its audited Final Results for the year ended 30 April 2025. Financial highlights: Revenue increased by 5% to £3,469,917 (2024: £3,308,359). Core recurring revenue model remains resilient.Available cash at the period end was £428,957 plus unutilised debtor drawdowns of £2...

October 31, 2025 1 EN
 PRESS RELEASE
Free
DXSP DXS Internation...

DXS International plc (AQSE:DXSP): ExpertCare featured in Innovate UK ...

DXS International plc (AQSE:DXSP): ExpertCare featured in Innovate UK Research Project DXS INTERNATIONAL PLC (AQSE: DXSP) ExpertCare featured in Innovate UK Research Project DXS International plc ("DXS" or "the Company"), a leading provider of digital clinical decision support solutions, is thrilled to announce that its leading-edge digital health solution, ExpertCare, has been independently reviewed by the prestigious York Health Economics Consortium (YHEC) with results that confirm its powerful impact on both clinical outcomes and NHS cost-efficiency.  Funded by DXS and Innovate UK and...

July 10, 2025 1 EN
Hybridan Team ... (+2)
  • Hybridan Team
  • Jon Levinson
DXSP DXS Internation...

Hybridan Research: DXS International plc: Experts to Decide

DXS’s ExpertCare, a digital solution platform, is selected for the Grow Digital Health Midlands Programme. This Programme is a collaboration between Health Innovation East and West Midlands, to provide a platform to encourage digital innovation to address the NHS most pressing challenges. DXS will be exposed to the largest NHS England region, encompassing 11 Integrated Care Systems, and a population of approximately 11.8m people. The programme is designed to help UK technology innovators scale p...

DXSP DXS INTERNATIONAL PLC
06/16/25 June 16, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch